Do tests devised to detect recent HIV-1 infection provide reliable estimates of incidence in Africa?

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 1, 2007, Pages 115-122

  Sakarovitch, Charlotte ^a   Rouet, Francois ^b   Murphy, Gary ^c   Minga, Albert K ^b   Alioum, Ahmadou ^a   Dabis, Francois ^a   Costagliola, Dominique ^a   Salamon, Roger ^a   Parry, John V ^c   Barin, Francis ^d  

^a INSERM   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d UNIVERSITÉ DE TOURS   (France)

Author keywords

Africa; HIV incidence; Immunoassay; Recent infection; Serological Testing Assays for the detection of Recent HIV Seroconversion (STARHS); Surveillance

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; BIOASSAY; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SIMULATION; VIRUS DETECTION;

AFRICA; AIDS SERODIAGNOSIS; BIOLOGICAL ASSAY; COHORT STUDIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; POPULATION SURVEILLANCE; PREVALENCE; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 34247601113     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318050d277     Document Type: Article

References (39)

1. Joint United Nations/World Health Organization Program on HIV/AIDS. AIDS epidemic update - December 2005. Available at: http://www.unaids.org/epi/2005/. Accessed March 12, 2006.
2. Whitworth JA, Mahe C, Mbulaiteye SM, et al. HIV-1 epidemic trends in rural south-west Uganda over a 10-year period. Trop Med Int Health. 2002;7:1047-1052.
3. Mbulaiteye SM, Mahe C, Whitworth JA, et al. Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in southwest Uganda: a cohort study. Lancet. 2002;360:41-46.
4. Wawer MJ, Serwadda D, Gray RH, et al. Trends in HIV-1 prevalence may not reflect trends in incidence in mature epidemics: data from the Rakai population-based cohort, Uganda. AIDS. 1997;11:1023-1030.
5. Leroy V, Van de Perre P, Lepage P, et al. Seroincidence of HIV-1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988-1992. AIDS. 1994;8:983-986.
6. Ades AE, Medley GF. Estimates of disease incidence in women based on antenatal or neonatal seroprevalence data: HIV in New York City. Stat Med. 1994;13:1881-1894.
7. Gregson S, Donnelly CA, Parker CG, et al. Demographic approaches to the estimation of incidence of HIV-1 infection among adults from agespecific prevalence data in stable endemic conditions. AIDS. 1996;10:1689-1697.
8. Brunet RC, Struchiner CJ. A non-parametric method for the reconstruction of age- and time-dependent incidence from the prevalence data of irreversible diseases with differential mortality. Theor Popul Biol. 1999;56:76-90.
9. Williams B, Gouws E, Wilkinson D, et al. Estimating HIV incidence rates from age prevalence data in epidemic situations. Stat Med. 2001;20:2003-2016.
10. Ghys PD, Brown T, Grassly NC, et al. The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics. Sex Transm Infect. 2004;80(Suppl 1):I5-I9.
11. Sakarovitch C, Alioum A, Ekouevi DK, et al. Estimating incidence of HIV infection in childbearing age African women using serial prevalence data from antenatal clinics. Stat Med. 2007;26:320-335.
12. Ades AE. Serial HIV seroprevalence surveys: interpretation, design, and role in HIV/AIDS prediction. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:490-499.
13. World Health Organization. Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond. 2006. Available at: http://www.who.int/hiv/mediacentre/news57/en/index.html. Accessed May 2, 2006.
14. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42-48.
15. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18:295-307.
16. Rawal BD, Degula A, Lebedeva L, et al. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr. 2003;33:349-355.
17. Kothe D, Byers RH, Caudill SP, et al. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr. 2003;33:625-634.
18. Suligoi B, Massi M, Galli C, et al. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr. 2003;32:424-428.
19. Barin F, Meyer L, Lancar R, et al. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol. 2005;43:4441-4447.
20. Parekh BS, McDougal JS. Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res. 2005;121:510-518.
21. Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95:1439-1444.
22. Gupta P, Kingsley L, Sheppard HW, et al. High incidence and prevalence of HIV-1 infection in high risk population in Calcutta, India. Int J STD AIDS. 2003;14:463-468.
23. Murphy G, Parry JV, Gupta SB, et al. Test of HIV incidence shows continuing HIV transmission in homosexual/bisexual men in England and Wales. Commun Dis Public Health. 2001;4:33-37.
24. InVS. Surveillance de l'infection à VIH-SIDA en France, 2003-2004. Bulletins Epidémiologiques Hebdomadaires. 2005;46-47:230-232.
25. Suligoi B, Galli C, Massi M, et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol. 2002;40:4015-4020.
26. Salamon R, Marimoutou C, Ekra D, et al. Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Côte d'Ivoire, 1997-2000. J Acquir Immune Defic Syndr. 2002;29:149-157.
27. Toni TD, Recordon-Pinson P, Minga A, et al. Presence of key drug resistance mutations in isolates from untreated patients of Abidjan, Cote d'Ivoire: ANRS 1257 study. AIDS Res Hum Retroviruses. 2003;19:713-717.
28. Suligoi B, Bossi V, Massi M, et al. Determinazione sierologica per l'identificazione delle infezioni recenti da HIV. STD News. 2004;22:6-9.
29. Martro E, Suligoi B, Gonzalez V, et al. Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. J Clin Microbiol. 2005;43:6197-6199.
30. Calypte Biomedical Corporation. Package insert. Calypte HIV-1 BED Incidence Assay. Enzyme immunoassay for population estimates of HIV-1 incidence. Available at: http://www.calypte.com/PRODUCTS/Incidence%20EIA.htm. Accessed May 2, 2006.
31. Msellati P, Sakarovitch C, Bequet L, et al. Decrease of human immunodeficiency virus prevalence in antenatal clinics in Abidjan, Cote d'Ivoire, 1995-2002. Int J STD AIDS. 2006;17:57-60.
32. Anglaret X, Diagbouga S, Mortier E, et al. CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients? J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:361-367.
33. Meyer L, Goujard C, Chaix M, et al. Lower CD4 counts in sub-Saharan subjects are observed at the time of HIV-1 primary infection and persist under HAART. Presented at: 10th International Workshop on HIV Observational Databases; 2006, Madrid.
34. Baillou A, Barin F, Allain JP, et al. Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations. J Infect Dis. 1987;156:830-833.
35. Young CL, Hu DJ, Byers R, et al. Evaluation of a sensitive/less sensitive testing algorithm using the BioMerieux Vironostika-LS assay for detecting recent HIV-1 subtype B′ or E infection in Thailand. AIDS Res Hum Retroviruses. 2003;19:481-486.
36. Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr. 1997;66(Suppl):460S-463S.
37. Keusch GT. The history of nutrition: malnutrition, infection and immunity. J Nutr. 2003;133(Suppl):336S-340S.
38. McDougal JS, Pilcher CD, Parekh BS, et al. Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries. AIDS. 2005;19(Suppl 2):S25-S30.
39. United Nations Program on HIV/AIDS. Statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. Statement following a meeting of the UNAIDS Reference Group for Estimates, Modelling and Projections held in Athens, Greece, December 13th 2005. Available at: http://www.epidem.org/publications.htm. Accessed May 2, 2006.